This report discusses the current state of the pharmaceutical industry – particularly in relation to the UK. It draws on a large body of evidence to highlight the key issues in the pharmaceutical industry – looking specifically at rates of innovation, clinical trials, and its relationship with the medical profession. It goes on to call for an improved regulatory structure to ensure that the industry delivers the drugs we need at prices which we can afford.